Revised estimates of overdiagnosis from the Canadian National Breast Screening Study

Preventive Medicine

Volumn 90, Issue , 2016, Pages 66-71

  Baines, Cornelia J ^a   To, Teresa ^b   Miller, Anthony B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Breast cancer; Mammography; Overdiagnosis; Randomized screening trials; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MIDDLE AGED; OVERDIAGNOSIS; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TUMOR INVASION; WOMEN'S HEALTH; BREAST TUMOR; CANADA; EARLY CANCER DIAGNOSIS; HEALTH SERVICE; MASS SCREENING; PROCEDURES;

ADULT; BREAST NEOPLASMS; CANADA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; PHYSICAL EXAMINATION; RISK FACTORS;

EID: 84977119063     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.06.033     Document Type: Article

References (24)

1. Baker, S.G., Prorok, P.C., Kramer, B.S., Lead time and overdiagnosis. J. Natl. Cancer Inst., 106(12), 2014 (pii: dju346).
2. Biller-Andorno, N., Juni, P., Abolishing mammography screening programs? A view from the Swiss Medical Board. N. Engl. J. Med. 370 (2014), 1965–1967.
3. Bleyer, A., Welch, H.G., Effect of three decades of screening mammography on breast cancer incidence. N. Engl. J. Med. 367 (2012), 1998–2005.
4. Canadian Partnership Against Cancer, Breast cancer control in Canada: a system performance special focus report. Appendix II, 2012, Canadian Partnership Against Cancer, Toronto.
5. Darby, S.C., Ewertz, M., McGale, P., Bennet, A.M., Blom-Goldman, U., Brønnum, D., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368 (2013), 987–998.
6. de Glas, N.A., de Craen, A.J.M., Bastiaannet, E., Op't Land, E.G., Kiderlen, M., van de Water, W., et al. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study. BMJ, 349, 2014, g5410.
7. Duffy, S.W., Parmar, D., Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res., 15, 2013, R41.
8. Etzioni, R., Gulati, R., Mallinger, L., et al. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann. Intern. Med. 68 (2013), 831–838.
9. Fletcher, S.W., Black, W., Harris, R., Rimer, B.K., Shapiro, S., Report on the International Workshop on Screening for Breast Cancer. J. Natl. Cancer Inst. 85 (1993), 1644–1656.
10. Helvie, M.A., Chang, J.T., Hendrick, R., Banerjee, M., Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer. Cancer 120:17 (2014), 2649–2656.
11. Independent UK Panel on Breast Cancer Screening, The benefits and harms of breast cancer screening: an independent review. Lancet 380 (2012), 1778–1786.
12. Kopans, D.B., Arguments against mammography screening continue to be based on faulty science. Oncologist 19 (2014), 107–112.
13. Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., et al. Breast-cancer screening—viewpoint of the IARC Working Group. N. Engl. J. Med. 372 (2015), 2353–2358.
14. McCaffery, K.J., Jansen, J., Laura, D., Scherer, L.D., Thornton, H., Hersch, J., et al. Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ, 352, 2016, i348.
15. Miller, A.B., Baines, C.J., To, T., Wall, C., Canadian national breast screening study: 1. Breast cancer detection and death rates among women age 40–49 years. Can. Med. Assoc. J. 147 (1992), 1459–1476.
16. Miller, A.B., Baines, C.J., To, T., Wall, C., Canadian national breast screening study: 2. Breast cancer detection and death rates among women age 50–59 years. Can. Med. Assoc. J. 147 (1992), 1477–1488.
17. Miller, A.B., Wall, C., Baines, C.J., Sun, P., To, T., Narod, S.A., Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ, 348, 2014, g366.
18. Prorok, P.C., Kramer, B.S., Miller, A.B., Study designs for determining and comparing sensitivities of disease screening tests. J. Med. Screen. 22:4 (2015), 213–220.
19. Smith, R.A., Counterpoint: overdiagnosis in breast cancer screening. J. Am. Coll. Radiol. 11 (2014), 648–652.
20. To, T., Wall, C., Baines, C.J., Miller, A.B., Is carcinoma in situ a precursor lesion of invasive breast cancer?. Int. J. Cancer 135 (2014), 1646–1652.
21. Welch, H.G., Black, W.C., Overdiagnosis in cancer. J. Natl. Cancer Inst. 102 (2010), 605–613.
22. Welch, H.G., Passow, H.J., Quantifying benefits and harms of screening mammography. JAMA Intern. Med. 174:3 (2014), 448–454.
23. Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., J. Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 332:7543 (2006), 689–692.
24. Zahl, P.-H., Jorgensen, K.J., Goetzsche, P.C., Overestimated lead times in cancer screening have led to substantial underestimation of overdiagnosis. Br. J. Cancer 109:7 (2013), 2014–2019.